vanadium pentoxide

04/25/2007 - "The induction of genes that mediate inflammation and immune responses, as well as suppression of genes involved in growth arrest appear to be important to the lung fibrotic reaction to V2O5."
01/01/2023 - "Low-dose vanadium pentoxide perturbed lung metabolism associated with inflammation and fibrosis signaling in male animal and in vitro models."
02/22/2010 - "Mice were pre-exposed by intranasal aspiration to RSV or media vehicle prior to intranasal aspiration of V2O5 or saline vehicle at day 1 or day 7. A parallel group of mice were treated first with V2O5 or saline vehicle at day 1 and day 7 then post-exposed to RSV or media vehicle at day 8. V2O5-induced airway inflammation and fibrosis were decreased by RSV pre- or post-exposure. "
03/01/2014 - "Pulmonary responses to V2O5, including dose-dependent increases in lung permeability, inflammation, collagen content, and dysfunction, were significantly greater in DBA/2J mice compared to C57BL/6J mice. "
01/01/2022 - "Compared to HDM alone, V2O5 co-exposure exacerbated HDM-induced airway inflammation with increased infiltration of inflammatory cells and elevated levels of Th1/Th2/Th17 and epithelial-derived (IL-25, TSLP) cytokines in the bronchoalveolar lavage fluids (BALFs). "

12/01/2020 - "This comprehensive study focuses on understanding the precise molecular interactions of vanadium pentoxide nanoparticles (VnNp) and evaluate their specific "nano" induced effects on MDA-MB-231 cancer cells. "
08/01/2014 - "These results confirm the absence of any significant dose-related effect on mouse lung tumor incidence in the study groups exposed to V2O5. "
12/01/2002 - "Under the conditions of this 2-year inhalation study, there was some evidence of carcinogenic activity of vanadium pentoxide in male F344/N rats and equivocal evidence of carcinogenic activity of vanadium pentoxide in female F344/Nrats based on the occurrence of alveolar/bronchiolar neoplasms. "
01/06/2023 - "Moreover, the matrix treatment (without V2O5) provided an optimal environment for tumor cell attachment and proliferation. "
11/15/2021 - "Photoelectrochemical aptasensor based on La2Ti2O7/Sb2S3 and V2O5 for effectively signal change strategy for cancer marker detection."

09/15/2021 - "In the present study, it will be shown that this type of catalyst is highly resistant to ABS poisoning for NH3-SCR reaction, overcoming a major issue afflicting the application of commercial V2O5-WO3/TiO2 catalyst at temperatures below the dew point of ABS. "
12/01/2018 - "In this work, an environmental friendly industrial regeneration approach has been proposed to remove the surface poisoning and recover the catalytic activity of waste V2O5-WO3/TiO2 catalyst. "
01/01/2018 - "New Insight into SO2 Poisoning and Regeneration of CeO2-WO3/TiO2 and V2O5-WO3/TiO2 Catalysts for Low-Temperature NH3-SCR."
06/05/1969 - "[Vanadium pentoxide poisoning]."
11/09/1957 - "[Vanadium pentoxide poisoning]."

04/12/2010 - "Mice sensitive to tumor promotion by V2O5 were also found to be more susceptible to V2O5-induced pulmonary inflammation and hyperpermeability (A/J>BALB>B6). "
04/12/2010 - "Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner."
02/22/2010 - "Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide."
12/01/1985 - "An experimental study was conducted to investigate the hypothesis that changes in pulmonary function induced by vanadium pentoxide (V2O5) inhalation would be accompanied by evidence of pulmonary inflammation. "
05/01/1996 - "NaVO3 and VOSO4, both very soluble forms of vanadium, tended to induce pulmonary inflammation and inflammatory cytokine mRNA expression more rapidly and more intensely than the less soluble form, V2O5. "

01/01/2023 - "Taken together, these results show that oxidative stress from environmental V+5, ingested at low levels, could alter metabolism to contribute to common human lung diseases.NEW & NOTEWORTHY We used relevant dietary and environmental doses of Vanadium pentoxide (V+5) to examine its metabolic impact in vitro and in vivo. "
01/01/2023 - "The results showed that non-cytotoxic exposures to V2O5 nanomaterials impact major metabolic pathways previously associated with human lung diseases and suggest that toxico-metabolomics may be useful to evaluate health risks from V2O5 nanomaterials."
04/01/1999 - "This study provides strong supporting evidence that inhaled V2O5 induces BHR and asthma in subjects previously free of lung disease; the abnormality may persist for up to 23 months following exposure; routine spirometry will not detect affected subjects."
04/01/1994 - "Inhalation of dust containing vanadium pentoxide (V2O5), a pentavalent compound of vanadium, has been reported to cause lung diseases. "